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ABSTRACT
Mitochondrial ribosomes and translation factors
co-purify with mitochondrial nucleoids of human
cells, based on affinity protein purification of
tagged mitochondrial DNA binding proteins.
Among the most frequently identified proteins
were ATAD3 and prohibitin, which have been
identified previously as nucleoid components,
using a variety of methods. Both proteins are
demonstrated to be required for mitochondrial
protein synthesis in human cultured cells, and
the major binding partner of ATAD3 is the mitochon-
drial ribosome. Altered ATAD3 expression also
perturbs mtDNA maintenance and replication.
These findings suggest an intimate association
between nucleoids and the machinery of protein
synthesis in mitochondria. ATAD3 and prohibitin
are tightly associated with the mitochondrial mem-
branes and so we propose that they support nucleic
acid complexes at the inner membrane of the
mitochondrion.
INTRODUCTION
Proteins associate with mitochondrial DNA (mtDNA) to
form nucleoprotein complexes, known as nucleoids (1).
Mitochondrial nucleoid proteins perform a variety of
functions, including organizing and protecting mtDNA.
When mtDNA is copied or expressed, ancillary factors
are recruited to the nucleoid; therefore, the mitochondrial
nucleoid is dynamic, it is not a single discrete entity.
Consequently, the complete characterization of the
protein repertoire of mitochondrial nucleoids will
probably require the application of several different
approaches. Previously, we isolated nucleoids from
lysates of rat liver mitochondria by affinity capture of a
generic DNA binding protein, and identified five known
or candidate nucleoid proteins (2). They were TFAM, the
mitochondrial transcription factor A (3); ATAD3, a
protein with displacement loop binding properties, which
has also been implicated in processes in mitochondria
other than DNA metabolism (4); hydroxyacyl dehydro-
genase A; NIPSNAP1, a mitochondrial protein linked to
amino acid metabolism, (5) and TUFM, the mitochon-
drial translation elongation factor (6). More recently, we
identified proteins that are more tightly associated with
mtDNA than TFAM, they included two cytoskeletal
proteins, b-actin and non-muscle myosin IIA that contrib-
ute to mtDNA maintenance (7). Enriched mitochondrial
nucleoprotein preparations have been isolated independ-
ently by immunocapture with antibodies to two known
mtDNA binding proteins, SSBP1 or mitochondrial
single-stranded DNA binding protein, and TFAM (8)
and by chemically cross-linking proteins to human
mtDNA (9). While these procedures identified many
plausible and established DNA interacting proteins, they
also contained probable contaminants, including 24 cyto-
solic ribosomal proteins in the latter case. In this article,
TFAM and SSBP1 were tagged and expressed in human
cells and candidate protein partners identified by mass
spectrometry, after tandem affinity chromatography.
Among the most frequently identified proteins associated
with mtDNA were components of mitochondrial ribo-
somes and other proteins known to be involved in
protein synthesis in mitochondria. Three other proteins
identified in the mitochondrial nucleoprotein prepar-
ations, ATAD3, prohibitin and CRIF1 (GADD45GIP1),
were investigated and each was demonstrated to contrib-
ute to mitochondrial protein synthesis in proliferating
human cells.
MATERIALS AND METHODS
Cell culture
Human osteosarcoma (HOS 143B cells) and human
embryonic kidney cells (HEK293T) were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM) and
10% fetal bovine serum. In the case of transgenic
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HEK293T cells (control, TFAM, SSBP1, ATAD3A and
ATAD3B), the serum was tetracycline-free and the
medium included 15 mg/ml of blastcidin and 100 mg/ml of
Zeocin or 100 mg/ml of hygromycin and 15 mg/ml of
blastcidin for control and transgene expressing cells,
respectively.
Affinity purification of nucleoids
Human cDNA, specifying TFAM, SSBP1, ATAD3B or
ATAD3A, was introduced into HEK293T cells
(Invitrogen) to establish inducible, transgenic cell lines.
Each transgene carried a carboxy-terminal linker
sequence (LEGTGGAG), followed by Strep II and
FLAG tags. Transgene expression was induced with
2–20 ng/ml doxycycline for 24–48 h. Mitochondria were
isolated by a method modified from 1 109 HEK293T
cells (8). Briefly, cells were disrupted by homogenization
in hypotonic buffer (20mM HEPES pH 8, 5mM KCl,
1.5mMMgCl2 and 2mM DTT), and mixed with a manni-
tol–sucrose buffer to final concentrations of 210mM
mannitol, 70mM sucrose, 20mM HEPES pH 8 and 2mM
EDTA (1MSB), prior to purification of mitochondria by
differential centrifugation. 2mg/mL mitochondria were
treated with 100 mg/ml DNase I (Sigma) for 30min at 4C
in 1MSB; digestion was terminated by the addition of
12mM EDTA, and the mitochondria were washed three
times with 1MSB. The mitochondria were further
purified by differential and (1.0M/1.5M) sucrose step-
gradient centrifugation. Mitochondria recovered from the
interface of the sucrose gradient were washed three times
with 1MSB. In some purifications, sucrose gradient-
purified mitochondria were incubated with trypsin (50mg/
ml; BDH) at 30C for 30min and then washed four times.
Digestion was terminated by resuspending the final pellet in
20 mg/ml bovine pancreatic trypsin inhibitor (Sigma).
Mitochondria lysed in 20mM HEPES pH 7.6, 5mM
EDTA, 150mM NaCl, 2mM DTT, 0.2mM PMSF,
1v/25v Roche protease inhibitor solution and 0.4%
n-dodecyl--D-maltoside at a final concentration of
5mg/ml were rotated for 20min, centrifuged at 1000gmax
for 10min and the supernatant was loaded onto a 0.25ml
Strep II-tag gravity column (IBA), which was flushed with
5 column volumes (CV) of wash buffer (20mM HEPES
pH 7.6, 1mM EDTA, 150mM NaCl, 2mM DTT, 0.2mM
PMSF, 1v/50v Roche protease inhibitor and 0.05%
dodecylmaltoside). Bound protein was eluted with
6 0.5 CV elution buffer (wash buffer and 10mM
desthiobiotin). After addition of the third aliquot of
elution buffer, the column was capped and incubated
overnight at 4C. For tandem affinity purifications
(TAPs), DTT was omitted during the StrepII purification
steps, and eluted fractions were pooled and loaded onto a
0.5ml FLAG tag agarose gravity column (Sigma). The
column was flushed with 20 CV of wash buffer, followed
by 5 CV of elution buffer (wash buffer plus 100 mg/ml
3FLAG peptide, Sigma). Eluted fractions from TAP
(Strep II and FLAG purifications) were pooled and
layered onto 20% sucrose in 20mM HEPES–KOH pH
7.6, 1mM EDTA, 150mM NaCl, 2mM DTT, 0.2mM
PMSF, 0.05% dodecylmaltoside and 1v/50v Roche
protease inhibitor tablet and centrifuged (100 000gmax,
2 h). The pellet of mitochondrial nucleoprotein was
dissolved in 4% SDS, 20mM Tris–HCl pH 7.4, 1mM
EDTA, 2mM DTT and stored at 20C.
Mass spectrometry
Protein samples were fractionated by SDS–PAGE, stained
with Commassie blue dye, excised and subjected to in-gel
tryptic digestion and then analysed in a MALDI–TOF–
TOF mass spectrometer (model 4800; ABI-Sciex), using
matrix a-cyano-4-hydroxycinnamic acid. Acquired
peptide mass data were compared with sequence databases
using MASCOT, and proteins were identified from a sig-
nificant peptide mass fingerprint (P< 0.05) or from
peptide fragmentation data (P< 0.05). Most proteins
were identified by both criteria (see Supplementary
Table S1).
For SILAC experiments, cells were grown in SILAC
medium (Dundee Cell Products) containing 13C6-lysine
and 13C6-arginine (K6R6) for six or more passages.
Lysed mitochondria from 1 108 HEK293T cells that
had been induced to express ATAD3B.FLAG.StrepII,
with 5 ng/ml of doxycycline for 24 h, were mixed with an
equal amount (w/w) of lysed mitochondria from cells
grown in 12C-lysine and 12C-arginine. The mitochondrial
1000gmax supernatant was loaded onto a column of
StrepII Sepharose (IBA GmBH), as already described.
The material eluted with desthiobiotin was precipitated
overnight with 20 ethanol, resuspended in 20 ml of 4%
SDS, 20mM Tris–HCl pH 7.4, 2mM EDTA containing
10mM DTT and alkylated in the dark for 30min with
30mM iodoacetamide (Sigma). Excess reagent was
quenched by the addition of DTT to 40mM. Samples
were fractionated by SDS–PAGE. Bands were excised,
digested in-gel with trypsin and analysed by LC/MS/MS
using an LTQ OrbiTrap XL mass spectrometer (Thermo),
following chromatography on a nanoscale reverse-phase
column (75mm i.d. 60mm; Nanoseparations, Nieukoop,
The Netherlands) with an acetonitrile gradient in 0.1%
(v/v) formic acid, 250 nl/min. Proteins were identified by
comparison of both peptide mass and fragmentation data
with National Center for Biotechnology Information
(NCBI) sequence database using the MASCOT algorithm
(10). Relative quantification of peptides containing
‘heavy’ and ‘light’ isotopes was performed with the
MAXQUANT suite of algorithms (11).
Cell transfection
For RNAi experiments, 143B osteosarcoma cells were
transfected once or twice with lipofectamine 2000
(Invitrogen) and 5 or 10 nM double-stranded (ds) RNA,
as previously described (2). After 48, 72 or 144 h, mitochon-
drial translation assays were performed (see below).
Double-stranded RNAs were 50-UCAAUGAGGAGAA
UUUACGGAAGCA-30 and 50-UGCUUCCGUAAAU
UCUC CUCAUUGA-30 (ATAD3 dsRNA1) and 50-UG
GUGAGACUGCAUUUUGA CAACUG-30 and 50-CA
GUUGUCAAAAUGCAGUCUCACCA-30 (ATAD3.
dsRNA2). PHB1 siRNA experiments employed 50-CACA
GCCUUCCUUCUGC UCUU-30 and 50-GAGCAGAAG
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GAAGGCUGUGUU-30. CRIF1 siRNA target sequences
were G1 5
0-ACAGATGATTGTGAACTGGCA-30 and G5
50-AAGAACGCGAATGGTACCCGA-30. Qiagen: allstar
negative control siRNA was used as a control dsRNA.
Plasmid DNA transfection was similar except that 1.5mg
plasmid DNA replaced dsRNA, and antibiotic selection
was applied after 24 or 48 h.
Estimation of transcript and mtDNA copy number
Mitochondrial mRNA abundance was estimated relative
to the mRNA for GAPDH. Total RNA was extracted
from cells with TRIzol reagent (Invitrogen) and cDNA
was generated with an Ominiscript reverse transcription
kit with random hexamer primers (Qiagen) according to
the manufacturer’s instructions. mtDNA copy number
and the relative abundance of mRNA were estimated by
quantitative PCR, as described before (12). Primers with
the following sequences were employed: APP, forward
50-TTTTTGTGTGCTCTCCCAGGTCT-30, reverse 50-T
GGTCACTGGTTGGTTGGC-30, APP probe 50-CCCT
GAACTGCAGATCACCAATGCGGTAG-30; COXII,
forward 50-CGTCTGAACTATCCTGCCCG-30, reverse
50-TGGTAAGGGAGGG ATCGTTG-30, probe 50-CGC
CCTCCCATCCCTACGCATC-30; Cytb, forward 50-GC
CTGCCTGATCCTCCAAAT-30, reverse 50-AAGGTAG
CGGATGATTCAGCC-30, probe 50-CACCAGACGCC
TCAACCGCCTT-30; ND1, forward 50-CCCTAAAA CC
CGCCACATCT-30, reverse 50-AGAGCGATGGTGAGA
GCTAAGG-30, probe 50-ATCACCCTCTACATCACCG
CCCCG-30; 16S rRNA, forward 50-TTTGCAAGG AGA
GCCAAAGC-30, reverse 50-AGACGGGTGTGCTCTTT
TAGC T-30, probe 50-AGACCCCCGAAACCAGACGA
GCTACC-30; 12S rRNA forward 50-CCCCAGGTTGGT
CAATTTC-30, reverse 50-CGGCTTCTATGACTTGGG
TTAA-30, probe 50-TGCAGCCACCGCGGTCA-30; 18S,
forward 50-TCGAGGCCCTGT AATTGGAA-30, reverse
50-CCCTCCAATGGATCCTCGTT-30, probe 50-AGTC
CACTTTAAATCCTT-30; GFP, forward 50-GGAGAG
GGTGAAGGTGATGC-30, reverse 50-ATCCGGATAA
CGGGAAAAGC-30, probe 50-CCTGTTCCATGGCC A
ACACTTG-30. Probes contained a 50-FAM fluorophore
and a 30-TAMRA quencher (Sigma Genosys). Cycle con-
ditions were the default setting on the ABI sequence
detection system 7700.
Iodixanol gradient analysis of mitochondrial lysates
Iodixanol gradient fractionation was as previously
described (7). Briefly, sucrose gradient-purified
HEK293T cell mitochondria were treated with trypsin,
as described above, lysed with 0.4% n-dodecyl--D-
maltoside and a 1000gmax supernatant loaded on a 20–
42.5% iodixanol gradient and centrifuged at 100 000gmax
for 14 h. Fractions of 0.5ml were collected from the base
of the tube, and the associated nucleic acid and proteins
were resolved by 1% agarose and 4–12% polyacrylamide
gel electrophoresis, respectively.
DNA analysis
DNA extraction and Southern blotting were performed as
described previously (2). Mitochondrial DNA copy
number was estimated by comparing the signal from a
radiolabelled probe with major non-coding region, nucleo-
tides 16343-151 of human mtDNA with that of a nuclear
18S rRNA probe.
Mitochondrial translation
The translation of proteins encoded in mtDNA was per-
formed as described before (13). Briefly, cells were
incubated with emetine for 10min to inhibit cytosolic
protein synthesis, before adding 35S-methionine for
30min, after which cells were lysed and fractionated by
SDS–PAGE (4–20% Tris–glycine PAG or as indicated in
the figure legends). Gels were dried and exposed to
phosphor plates, and the signals quantified with a
TyphoonTM phosphorimager (GE Healthcare).
Immunoblotting
Immunodetection utilized antibodies to mouse
anti-TUFM (1:1000, Abnova), mouse monoclonal
anti-Flag M2 (1:1000, Sigma), rabbit anti-POLMRT
(1:1000, Abcam), rabbit anti-TOM20 (1:20 000, Santa
Cruz), rabbit anti-MRPL11 (1:1000, cell signaling),
rabbit anti-prohibitin (1:500 BioLegend), mouse
anti-MRPS2 (1:500 Abcam), rabbit anti-PTCD3 1:500
(Abcam), rabbit anti-HSPD1 1:5000 (Abcam), rabbit
anti-UQCRC1 (complex III): 1:3000 (Sigma),mouse
anti-SDH (SDHB, complex II), 1:500 (Mitoscience),
rabbit anti-cytochrome oxidase II 1:200 (Abcam), rabbit
anti-ERAL1 (1:2000) (ProteinTech), mouse anti-GAPDH
(1:20 000) (Abcam), rabbit anti-H2A and anti-H2B
(1:2000) (Abcam) and anti-PAPM (1:1000) (Abcam).
Rabbit anti-SSBP1 (1:500) and rabbit anti-TFAM
(1:20 000) were kind gifts of Drs M. Zeviani and R.
Wiesner, respectively. Rabbit anti-ATAD3, 1:50 000;
anti-CRIF1, 1:2000, anti-ATPase g subunit, 1:5000;
anti-NDUFS1, 1:4000 and chicken anti-FA11 (1:10 000)
were raised against recombinant proteins produced
in-house. Secondary antibodies were anti-rabbit or
anti-mouse HRP 1:1000 (Promega).
Confocal microscopy
Mitochondrial DNA was visualized using mouse
anti-DNA (1:200) (Novus Biologicals) and goat
anti-mouse-Alex-Fluro488 (1:1000) (Invitrogen);
ATAD3.HA was detected using rat anti-HA (1:1000)
(Roche) and goat anti-rat-Alex-Fluro647; Crif1-Flag
was detected using mouse anti-Flag (1:1000, Sigma) and
goat anti-mouse Alex-Fluro488; endogenous ATAD3
was detected using rabbit anti-ATAD3 (1:2000, made
in-house). Slides were mounted using ProLong_Gold
antifade. Cells were imaged with an LSM 510 Meta
confocal microscope (Zeiss) used in conjunction with
the LSM 510 software. Images were acquired with a
Zeiss 63 /1.40 oil immersion objective, set at zoom 2.4.
MitoTracker orange signal was pseudo-coloured red to
improve contrast. Images were edited in Photoshop
Elements (Adobe).
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ATAD3 Immunoprecipitation
Two hundred microlitre protein A sepharose (GE
Healthcare) pre-incubated with rabbit anti-ATAD3
serum (or an equal volume of rabbit preimmune serum)
was cross-linked by BS3 (bis-sulphosuccinimidyl suberate,
Thermo Scientific), according to the manufacturer’s
protocol. The beads were incubated with 1ml of the mito-
chondrial 1000gmax supernatant prepared as described
above for overnight at 4C. Beads were washed five
times with 200 ml mitochondria lysis buffer before
removal of bound proteins by boiling in SDS sample
buffer. Samples were resolved by SDS–PAGE, transferred
to nitrocellulose and probed with various antibodies.
Deposition of data
Mass spectrometric data associated with SILAC-labelled
affinity purification of ATAD3 have been deposited at the
TRANCHE repository (https://proteomecommons.org)
and may be downloaded using the following hash:
DqM6cArdfZugsbmp7VqMhCN10zEgPrrrDjppdB+yV6
6a1QDIUS9sbDP1N+e VOZlhPHzG1DTeV+j7i1oGch
Gl6YfKot4AAAAAAAAVPA==
RESULTS AND DISCUSSION
Isolation and characterization of human mitochondrial
nucleoids
In five independent TAP experiments, nucleoids were
isolated from the mitochondria of human embryonic
kidney (HEK293T) cells expressing StrepII and FLAG-
tagged forms of TFAM or SSBP1 and identified by mass
spectrometry (see ‘Materials and Methods’ section). The
procedure enriched the bait protein greatly and simplified
the protein profile considerably (Supplementary Figure
S1). The identified proteins are listed in Table 1 with
details in Supplementary Table S1. Several of the candi-
date nucleoid proteins, ATAD3, prohibitin, TUFM,
b-actin and TFAM, were also present in enriched mito-
chondrial nucleoprotein preparations from rat liver
isolated by other methods (2,7), whereas none of the
proteins that co-purified with tagged TFAM or SSBP1
were identified by mass spectrometry when mitochondrial
lysates of control HEK293T cells were subjected to the
first affinity purification step (14). ATAD3 has been
implicated in mtDNA metabolism previously, as it binds
preferentially to DNA structures with a displacement
loop in vitro, and its abundance in cells affects mtDNA
topology, the dimensions of the mitochondrial nucleoid
and the abundance of 7S DNA, which forms displace-
ment loops (2,15,16). Its presence in all TAP preparations
of nucleoids (Table 1) supports the view that ATAD3 is
associated with many, if not all, mitochondrial nucleoids,
and, as shown below, contributes to protein synthesis in
the mitochondrion. The identification of b-actin in three
of the five TAPs (Table 1) supports the earlier assignment
of b-actin as a protein that interacts with the mitochon-
drial nucleoid (7). CKAP4, cytoskeletal-associated
protein 4, which has hitherto been linked to the endoplas-
mic reticulum (17), was identified in two TAPs, and so is a
candidate for linking mitochondrial nucleoids to the
cytoskeleton. Histones appeared in all the preparations;
however, their abundance was reduced considerably
by treatment of isolated mitochondria with trypsin,
prior to lysis and TAP (Supplementary Figure S2). It is
not known if the residual histones that survive trypsin
treatment are genuine mitochondrial proteins.
Many components of mitochondrial ribosomes were
identified in the TFAM and SSBP1 affinity-purified prep-
arations (Table 1). However, no mitochondrial ribosome
component, or candidate nucleoid protein, was identified
when the FLAG and StrepII tags were linked to a
mitochondrially targeted form of GFP (mtGFP) and
affinity purified from HEK293T cells (Supplementary
Figure S3-A). However, HSPA9 (HSP75) was present as
before, suggesting that it is induced in response to high-
level expression of many transgene products. Nor were
there any mitochondrial nucleoid proteins or translation
factors, with the possible exception of SF2P32 (18),
when tagged NIPSNAP2 was affinity purified from
mitochondria of HEK293T cells (Supplementary Figure
S3-B). Thus, the expression and purification system used
does not systematically isolate mitochondrial ribosomes
and translation factors, and so the co-purification of
such factors with TFAM and SSBP1 implies bona fide
interactions.
Nucleoid components involved in protein translation
in mitochondria
The presence in TAP nucleoprotein complexes of 12–25
protein components of mitochondrial ribosomes and of
pentatricopeptide protein 3 (19,20) and TUFM (6)
(Table 1; Supplementary Tables S1 and S2), suggested a
link between mitochondrial nucleoids and the mitochon-
drial translation apparatus. This interpretation was sup-
ported by immunoblot analysis of the StrepII affinity
purified material, which contained a substantial amount
of a small ribosome assembly protein, ERAL1 (21,22) and
two mitochondrial ribosomal proteins, MRPS2 and
MRPL11, yet very little respiratory chain protein
(Supplementary Figure S4). Moreover, analysis of all the
proteins in the gel, with an OrbiTrap mass spectrometer,
after additional TAPs of TFAM, identified 31 and 56
mitochondrial ribosomal subunits in two experiments
(Supplementary Table S2).
Mitochondrial mRNAs are associated with high-density
nucleoprotein complexes
The co-purification of mitochondrial ribosomes and ancil-
lary factors with mitochondrial nucleoids (Table 1), sug-
gested an intimate association between the two types of
nucleic acid-containing complex, and a previous study
identified a number of candidate nucleoid proteins
among those proteins immunoprecipitated with mtRRF,
a mitochondrial ribosome recycling factor (23).
Mitochondrial RNA and DNA also co-fractionate on
20–42.5% iodixanol gradients (Figure 1a), although this
could reflect identical buoyant densities, rather than a
physical interaction. In any case, both complexes depend
on protein for their position on the gradients, as
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mitochondrial DNA and RNA stripped of protein barely
entered 20–42.5% iodixanol gradients, and so they were
found near the top of the density gradient (Figure 1b). The
vast majority of messenger RNAs were contained in the
ribonucleoprotein complexes that coincided with mito-
chondrial ribosomes and nucleoids (Figure 1a, c and d),
suggesting that mitochondrial mRNAs are not free in the
matrix; an arrangement that may be designed to avoid
degradation by RNases and damage by free radicals
generated in the mitochondrion.
For unknown technical reasons possibly related to trace
RNase contamination, mtDNA and mtRNA were partly
resolved in some experiments (Figure 1c and d).
Messenger RNAs and 16S rRNA peaked in one fraction
(No. 8, in the example shown), whereas 12S rRNA was
most abundant in an adjacent fraction (No. 9) (Figure 1c).
The partial resolution of DNA and RNA protein
complexes enabled specific proteins to be assigned to par-
ticular complexes. Messenger RNAs displayed a similar
distribution to the 39S subunit (16S rRNA and
MRPL11) on the iodixanol gradients (Figure 1e), suggest-
ing that mRNAs are more tightly bound to the large, as
opposed to the small, subunit of the mitochondrial
ribosome, or that they associate with an unknown
complex of similar buoyant density to the 39S subunit.
As expected, TFAM, SSBP1 and the mitochondrial
RNA polymerase (POLRMT) co-fractionated with
mtDNA, whereas a known RNA transacting protein,
mitochondrial polyA polymerase, PAPM showed a
similar distribution to mRNA and the 39S subunit
(Figure 1c–e). The majority of mitochondrial proteins
were located in fractions near the top of the gradient,
including proteins of the oxidative phosphorylation
system (Supplementary Figure S5).
ATAD3 co-fractionates with mitochondrial RNA,
co-purifies with mitochondrial ribosomes and contributes
to mitochondrial protein synthesis
In those iodixanol gradients where mitochondrial RNA
and DNA were not coincident, ATAD3 protein peaked
with the mRNAs, the 39S subunit and the mitochondrial
polyA polymerase (Figure 1c and e), suggesting that it
might play a role in mitochondrial translation, or RNA
metabolism. The co-purification of only a small fraction of
ATAD3 with tagged TFAM and SSBP1 (Supplementary
Table 1. Proteins identified by MALDI–TOF–TOF mass spectrometry from five StrepII and FLAG tag tandem affinity purifications of TFAM
or SSBP1, from DNA-enriched mitochondrial supernatants of HEK293T cells (see ‘Materials and Methods’ section)
A: TFAM-Flag-StrepII B: SSBP1-Flag-StrepII C: TFAM-Flag-StrepII D: SSBP1-Flag-StrepII E: TFAM-Flag-StrepII
ATAD3A ATAD3A ATAD3A ATAD3A ATAD3A
SSBP1 TFAM SSBP1 TFAM SSBP1
TUFM TUFM TUFM DHX30 TUFM
DHX30 DHX30 DHX30 PTCD3 PTCD3
PTCD3 b-actin PTCD3 PHB2 b-actin
PHB1 PHB2 LRP59
CKAP4 b-actin CRIF1
LRP59 CKAP4
CRIF1 LRP59
MRPS5, MRPS7, MRPS9,
MRPS10, MRPS11,
MRPS14, MRPS16,
MRPS17, MRPS22,
MRPS23, MRPS24,
MRPS27, MRPS29,
MRPS31, MRPS35
MRPS5, MRPS7,
MRPS9, MRPS10,
MRPS14, MRPS23,
MRPS26, MRPS27,
MRPS28, MRPS29,
MRPS31, MRPS34
MRPS5, MRPS9, MRPS10,
MRPS14, MRPS22,
MRPS26, MRPS27,
MRPS28, MRPS29,
MRPS31
MRPS9, MRPS18B,
MRPS26, MRPS30
MRPS5, MRPS9,
MRPS10, MRPS22,
MRPS23, MRPS26,
MRPS27, MRPS28,
MRPS29, MRPS31,
MRPS34
MRPL4a, MRPL22,
MRPL23, MRPL35,
MRPL38, MRPL39,
MRPL41, MRPL43,
MRPL49, ICT1
MRPL4a, MRPL22,
MRPL23, MRPL35,
MRPL38, MRPL39,
MRPL41, MRPL43,
MRPL49, ICT1
MRPL11, MRPL23, MRPL43 MRPL4, MRPL11,
MRPL15, MRPL19,
MRPL28, MRPL37,
MRPL38, MRPL44
MRPL3, MRPL4,
MRPL4a, MRPL15,
MRPL22
Histones: Histone: Histones: Histones: Histones:
H2B, H4F H2A2 H2A2, H2B.1, H3, H4 H2A, H2B, H4 H2A, H2B, H3.3, H4
The list comprises proteins identified in two or more mitochondrial nucleoid preparations. Proteins identified once only, which do not appear in the
table were: leucine rich PPR-motif containing protein (LRP130, or LRPPRC), trifunctional enzyme subunit alpha (HADHA), RNA
methyltransferase-like 1, Splicing factor-2 associated protein p32 (SF2P32), dihydrolipoamide branch chain transacylase (DBT), serine
hydroxymethyl transferase (SHMT), the mitochondrial phosphate carrier (SLC25A3), C4orf14 (NOA1)—see accompanying article, and protein
RPL18a of the 60S cytosolic ribosome. The bait protein was identified in all TAPs (Supplementary Table S1). Abbreviations are as follows:
ATAD3, ATPase family AAA domain-containing protein 3, DHX30 (putative ATP-dependent RNA helicase), TUFM (mitochondrial translation
elongation factor), PHB 1 or 2 (prohibitin), PTCD3 (pentatricopeptide repeat-containing protein 3), LRP59 (leucine-rich protein 59), CRIF1 or
Gadd45GIP1 (growth arrest and DNA damage-inducible proteins-interacting protein 1), the peptidyl tRNA hydrolase, ICT1, CKAP4 (cytoskeletal
associated protein 4). Further details of the identification of proteins appear in Supplementary Table S1, and the mitochondrial ribosomal proteins
(MRPs) identified in the TAPs are collated in Supplementary Table S2, and shown in parallel with those MRPs identified in subsequent analyses.
Histones were for the most part degraded when mitochondria were incubated with trypsin prior to lysis (Supplementary Figure S2). HSPA9 was
identified in four TAPs but is not listed in the table, as it was also associated with affinity-purified mitochondrially targeted GFP (Supplementary
Figure S3-A).
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Figure S4) also implied that the protein might have part-
ners other than the mitochondrial nucleoid. In an effort
to identify new partners of ATAD3, a FLAG.StrepII
tagged version of ATAD3B (ATAD3B.FS) was expressed
in HEK293T cells. Although mitochondrial ribosomal
proteins MRPS18B and MRPL11 co-purified with
ATAD3B.FS based on immunoblotting (Supplementary
Figure S6), the enrichment of ATAD3B.FS was not as
great as that of other tagged proteins (Supplementary
Figure S4). Therefore, as a more sensitive screen for
Figure 1. Fractionation of mitochondrial nucleoprotein complexes on iodixanol gradients. (A) Mitochondrial 1000gmax supernatants from HEK293T
cells were fractionated on 20–42.5% iodixanol gradients, and extracted nucleic acids from each fraction were separated by agarose gel electrophoresis
and stained with ethidium bromide. (B) Protease-treated mitochondrial nucleic acids fractionated on a 20–42.5% iodixanol gradient. (C) The chart
shows the relative abundance of five mitochondrial RNAs (12S rRNA, 16S rRNA, cox2, cytb and nd1) based on quantitative RT-PCR (see
‘Materials and Methods’ section); above the chart is a transilluminator image of the ethidium bromide-stained RNA from each fraction. The
qPCR results for the three mRNAs (cox2, cytb and nd1) were similar and so they were grouped together (blue line). Each fraction was ‘spiked’
with an equal amount of synthetic GFP transcript (green line), as a control. Quantitative RT-PCR of 18S rRNA was performed in parallel, but none
was detected, indicating that any contamination with RNA of cytosolic ribosomes was below the limits of detection. (D) Ethidium bromide staining
and qPCR detection of mtDNA based on the amplification of five mitochondrial genes (see ‘Materials and Methods’ section). (E) The DNA and
RNA detected by transillumination from panels (C) and (D) are displayed above a series of immunoblots for a range of mitochondrial proteins (see
text for details). The boxed area includes all the results for fraction 8, in which mRNA peaked. (F) Immunoblots of mitochondrial 1000gmax
supernatants of HEK cells before (input) and after IP with anti-ATAD3 antibody. The control was instead incubated with preimmune serum.
(G) The products of mitochondrial protein synthesis were labelled with 35S-methionine in 143B cells subjected to one or two rounds of transfection
with dsRNA1 targeting ATAD3 (Ri) or mock transfected (C) cells. Large gel image: mitochondrial translation products at the base of the panel are
immunoblots of the same cell lysates probed with antibodies to ATAD3 or GAPDH.
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protein partners of ATAD3, stable isotope labelling of
proteins in cell culture (SILAC) coupled to Orbitrap MS
analysis was performed (24). Heavy (or light) labelled
mitochondria, isolated from HEK293T cells expressing
ATAD3B.FS, were mixed with an equal amount of light
(or heavy) labelled mitochondria from uninduced
HEK293T cells. In the interpretation of these experiments,
affinity-purified proteins from the mixed mitochondrial
lysates were considered to be associated with the bait
protein when they were present in a 2-fold, or greater,
excess over proteins in control mitochondria. Forty-six
proteins fulfilled these criteria (Table 2 and
Supplementary Table S3); the list was dominated by com-
ponents of the mitochondrial ribosome and other proteins
involved in mitochondrial RNA metabolism. Thirty-five
of the proteins were MRPs, and five others (PTCD3,
DHX30, LRP130, OXA1 and FASTKD2) have been
implicated in mitochondrial translation or RNA metabol-
ism (25–28). Little is known about human GTP-binding
protein 10 (GTPBP10 or OBGH2), but its bacterial homo-
logue obg 2, has been linked to ribosome maturation in
prokaryotes (29). GTPBP5 (OBGH1) has been reported to
localize to mitochondria, whereas GTPBP10 (OBGH2)
was found exclusively in the nuclei of HeLa cells in a
previous study (30). The other candidate partners of
ATAD3B: HADHA, LRP130, DHX30, ATAD3A and
TiD1 (Table 2), are all potential nucleoid-interacting
proteins based on earlier reports (2,8,31).
A SILAC experiment using ATAD3A as the bait
protein also yielded many components of the 55S
ribosome (Table 3 and Supplementary Table S4).
Forty-five of the top 54 proteins were 55S ribosome com-
ponents (including ICT1), and 65 MRPs achieved a better
than 2:1 ratio (Supplementary Table S4), accounting for
80% of the mitochondrial ribosome. Although both 28S
and 39S subunits were well represented, there was a bias
towards the large subunit: the first 31 proteins on the list
included 23 components of the 39S subunit, whereas the
highest scoring protein of the 28S subunit was 32nd on the
list (Supplementary Table S4). This bias suggests that
ATAD3A interacts (directly or indirectly) with the
39S subunit, as opposed to the 28S subunit. This detail
aside, the mitochondrial ribosome is the prime candidate
partner of both ATAD3A and ATAD3B (Table 4). Of
the other proteins co-purifying with recombinant
ATAD3A (Table 3 and Supplementary Table S4),
GTPBP5 and GTPBP10 rise to seventh and ninth on the
list of candidate protein partners of ATAD3A, respect-
ively, if the mitochondrial ribosomal proteins are
conflated as the 55S ribosome, rather than being scored
individually. GTPBP10 was also a candidate partner of
ATAD3B (Table 4), and GTPBP5 is another homologue
of the Era/Obg family (29), as is the proposed
28S assembly factor, ERAL1 (21), which was also
among the potential partners of ATAD3A (Table 3 and
Supplementary Table S4). A fourth member of the family,
C4orf14 associates specifically with the 28S subunit (see
accompanying article). Thus, it appears that at least four
members of the Era/Obg family (GTPBP5/OBGH1,
Table 3. ATAD3A partner proteins based on SILAC analysis
Proteins with links to mitochondrial translation or RNA metabolism
MRPs 69 mitochondrial ribosomal proteins
(41 MRPL, 28 MRPS)
MRP63 mitochondrial ribosomal protein 63
ICT1 Peptidyl-tRNA hydrolase ICT1, mitochondrial
ARL2 ADP-ribosylation factor-like protein 2
GTPBP5 GTP-binding protein 5;Protein obg homolog 1
GTPBP10 GTP binding protein 10; Protein obg homolog 2
IARS2 Isoleucine–tRNA ligase
PTCD3 Pentatricopeptide repeat-containing protein 3
RPUSD4 RNA pseudouridylate synthase domain-containing
protein 4
NUBPL Nucleotide-binding protein-like
ERAL1 Conserved ERA-like GTPase
TUFM Mitochondrial elongation factor Tu
CRIF1 Growth arrest and DNA damage-inducible
proteins-interacting protein 1
FASTKD5 FAST kinase domain-containing protein 5
DDX28 Mitochondrial DEAD box protein 28;probable
ATP-dependent RNA helicase
TRUB2B Probable tRNA pseudouridine synthase 2
LRP130 Leucine-rich PPR motif-containing protein; LRPPRC
MTERFD1 mTERF domain-containing protein 1
GUF1 GTP-binding protein GUF1 homolog
POLRMT Mitochondrial DNA-directed RNA polymerase
MRPP3 Mitochondrial ribonuclease P protein 3
METT11D1 Methyltransferase 11 domain-containing protein 1
PHB2 Prohibitin 2;BAP37
Proteins with links to lipid metabolism
STARD9 StAR-related lipid transfer protein 9
HADHA Trifunctional enzyme subunit alpha
HADHB Trifunctional enzyme subunit beta
SLC25A1 Tricarboxylate transport protein
SC2 trans-2,3-enoyl-CoA reductase
SPTLC1 Serine palmitoyltransferase 1
The proteins listed were identified in one SILAC experiment as the
most likely protein partners of ATAD3A, based on mass spectrometry
of affinity captured ATAD3A.Flag.StrepII (see main text and
Supplementary Table S4). The proteins are grouped by known or
inferred function. The complete list of proteins appears in
Supplementary Table S4.
Table 2. ATAD3B partner proteins based on SILAC analysis
Mitochondrial translation associated proteins
MRPs 35 mitochondrial ribosomal proteins (20 MRPL,
15 MRPS)
PTCD3 Pentatricopeptide repeat-containing protein 3
FASTKD2 FAST kinase domain-containing protein 2
CRIF1 Growth arrest and DNA damage-inducible
proteins-interacting protein 1
GTPBP10 GTP binding protein 10; Protein obg homolog 2
ATAD3A ATPase family AAA domain-containing
protein 3A
OXA1 Mitochondrial inner membrane protein OXA1L
Nucleoid-interacting proteins
DHX30 Putative ATP-dependent RNA helicase DHX30
LRP130 Leucine-rich PPR motif-containing protein;
LRPPRC
DNAJA3 (TID1) DnaJ homolog subfamily A member 3,
mitochondrial
HADHA Trifunctional enzyme subunit alpha
The proteins listed were identified in SILAC experiments as the most
likely protein partners of ATAD3B, based on mass spectrometry of
affinity captured ATAD3B.Flag.StrepII (see main text and
Supplementary Table S3). Two chaperones that were also found
associated with mtGFP (Supplementary Figure S3-A) were disregarded.
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GTPBP10/OBGH2, ERAL1 and C4orf14) have been
retained in eukaryotes to enable translation of proteins
in mitochondria.
STARD9 (START domain-containing protein 9) was
high on the list of putative binding partners of
ATAD3A. This interaction is plausible, since STAR-
domain containing proteins are involved in cholesterol
and lipid channelling, and ATAD3A has been implicated
in cholesterol uptake by mitochondria (4). Also, the
storage of intestinal fat is reduced in nematodes when
ATAD3 is scarce (32). ATAD3A studies may thus offer
insight into lipid metabolism and the, as yet poorly under-
stood, role of mitochondrial cholesterol in non-
steroidogenic cells. C18orf19 was the single strongest
candidate partner protein of ATAD3A (Supplementary
Table S4); however, its function is not known.
Immunoprecipitation (IP) of endogenous ATAD3 from
HEK293T cells, using an anti-ATAD3 antibody
corroborated the SILAC-affinity purification analyses,
inasmuch as four subunits of the 55S ribosome were
captured by the antibody (Figure 1f). CRIF1 and the
mitochondrial DNA polymerase, POLG1, produced the
strongest IP to input signals. However, POLG1 displayed
the smallest difference between ATAD3 IP and mock pre-
cipitation. Hence, CRIF1 was the single most likely
partner of ATAD3, of the proteins tested, based on IP
(Figure 1f).
Since the candidate protein partners of ATAD3A and
ATAD3B were suggestive of interactions with the mito-
chondrial ribosome, we next assessed the contribution of
endogenous ATAD3 to mitochondrial translation by
silencing ATAD3A and ATAD3B in human osteosar-
coma cells. Gene silencing of ATAD3 for 48 or 72 h
severely impaired mitochondrial protein synthesis,
compared to mock transfected cells, or cells trans-
fected with a scrambled dsRNA, based on 35S-methionine
labelling of mitochondrial translation products (Figure 1g
and Supplementary Figure S7).
ATAD3 and mtDNA metabolism
ATAD3 was found previously in highly enriched mito-
chondrial nucleoprotein preparations that were largely
free of ribosomes (2,7), and in this study it was identified
in all the TAPs of two mtDNA binding proteins (Table 1).
However, SILAC analysis suggested the major partner of
recombinant ATAD3 to be the mitochondrial ribosome
(Table 4). The co-fractionation of endogenous ATAD3
primarily with mitochondrial RNA (Figure 1e), and the
pronounced impairment of mitochondrial protein synthe-
sis in response to ATAD3 gene-silencing (Figure 1g) also
argued in favour of a role for the protein in mitochondrial
translation. To investigate ATAD3’s role in mtDNA me-
tabolism further, a haemagglutinin (HA)-tagged form of
ATAD3B was established in HEK293T cells
(Supplementary Figure S8). Expression of the transgene
led to a 30% reduction in mtDNA copy number, over the
course of 6 days (Figure 2a). This was a marginally
stronger phenotype than that observed for ATAD3
gene-silencing, which caused a 20% decrease in mtDNA
copy number (2). In contrast, elevated expression of HA-
tagged POLG2 in HEK293T cells had no effect on
mtDNA copy number (data not shown). The impact of
ATAD3B.HA on mtDNA was more pronounced when
mtDNA copy number was first reduced to 20% of
normal with ethidium bromide. In control cells, mtDNA
copy number returned to normal within 4 days of removal
of the drug, whereas there was a marked impairment of
mtDNA replication in cells expressing ATAD3B.HA
(Figure 2b), or ATAD3B.FS (Supplementary Figure S9-
A). Analysing the distribution of ATAD3.HA and
mtDNA in HEK293T cells suggested the underlying
problem for mtDNA might be a shortage of interacting
ATAD3. There was good co-localization 24 h after the in-
duction between mtDNA and ATAD3B.HA (Figure 2c),
and restoration of mtDNA copy number was similar to
controls at this time point (Figure 2b). However, at later
time points, when copy number was lagging appreciably
behind that of controls (Figure 2b), ATAD3B.HA formed
foci that did not co-localize with mtDNA (Figure 2d and
e), and these foci appeared to include the endogenous
protein, as immunocytochemistry with an antibody to
ATAD3 produced similar results (Supplementary Figure
S9-B). ATAD3 gene-silencing diminished picogreen
staining of mtDNA and depleted cells of detergent-
resistant mtDNA multimers held together by protein (2),
and elevated ATAD3B expression produced the same two
phenotypes (Figure 3a and b). Thus, three analyses of
mtDNA, copy number, picogreen staining and
protein-dependent multimers, suggest that over-expression
of ATAD3B.HA results in loss of function of endogenous
ATAD3, in relation to mtDNA transactions, which might
be explained by the aggregation of the protein, separate
from mtDNA (Figure 2d and e). Expression of
ATAD3B.HA also altered the features of mitochondrial
replication intermediates (Figure 3c). Specifically, there
was an increase in duplex DNA intermediates (resolving
on the replication fork, or y, arc), and a decrease in the
sub-y arc of RNA-containing intermediates (Figure 3c),
which are indicative of a change in the mode or mechan-
ism of mtDNA replication [for details, see Ref. (33)].
Therefore, native ATAD3 may well participate in
mtDNA replication.
If some native ATAD3 interacts directly with mtDNA,
as implied by the results already described (Figures 2
and 3), why was TFAM not among the candidate
Table 4. Shared candidate partner proteins of ATAD3A and
ATAD3B
MRPs Mitochondrial ribosomal proteins (69 for ATAD3A,
35 for ATAD3B)
PTCD3 Pentatricopeptide repeat-containing protein 3
GTPBP10 GTP binding protein 10; Protein obg homolog 2
CRIF1 Growth arrest and DNA-damage-inducible
proteins-interacting protein 1
LRP130 Leucine-rich PPR motif-containing protein; LRPPRC
DNAJA3
(TID1)
DnaJ homolog subfamily A member 3,
mitochondrial
HADHA Trifunctional enzyme subunit a
The list is conflated from Supplementary Tables S3 and S4.
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partner proteins identified in the SILAC experiments
(Tables 2 and 3)? Comparison of the results for the
affinity capture of mtDNA binding proteins (TFAM and
SSBP1) and ATAD3 suggests that the isolation procedure
identifies only the most abundant partners of the bait
protein. In the case of nucleoid capture, DNA polymerase
g was enriched based on immunoblotting (Supplementary
Figure S4), yet not sufficiently to be visible by Coomassie
staining and so it was not identified by mass spectrometry
(Table 1), presumably because only a subset of molecules
is undergoing replication at any one time. In the same
vein, ribosomes are numerically superior to nucleoids
and so more ATAD3 will be associated with 55S ribo-
somes than with mtDNA, assuming it binds to both.
Furthermore, in the SILAC experiments, heavy and light
forms of the various proteins were present on the same
Figure 2. Elevated expression of HA tagged ATAD3B impedes mtDNA replication by concentrating the protein in foci separate from mitochondrial
nucleoids. (A) HEK293T cells carrying an ATAD3B transgene with an HA tag were induced to express the recombinant protein with 50 ng/ml
doxycyline for 6 days. DNA was harvested daily and the mtDNA copy number assayed by qPCR. Controls were HEK293T cells transformed with
an empty vector and maintained in the same dose of drug. (B) qPCR estimation of mtDNA copy number after harvesting DNA from cells expressing
ATAD3B.HA protein, or control cells, at daily intervals, having first reduced mtDNA copy number to 20% of normal by exposure to 50 ng/ml
ethidium bromide for 72 h. The cells were maintained in 50 ng/ml doxycycline throughout the experiment. For charts (A) and (B), n=3 experiments,
error bars are 1 SD from the mean. The distribution of mitochondrial nucleoids (anti-DNA antibody) and ATAD3B.HA (anti-HA antibody) was
determined by confocal microscopy 24, 72 and 120 h after induction of the transgene with 50 ng/ml doxycycline [panels (C–E), respectively].
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column, and so there may have been some transfer of free
TFAM, POLG1 and SSBP1 (Figure 1e) from the control
mitochondrial lysates to the recombinant ATAD3 bound
nucleoids, which would have the effect of reducing the
bait-associated protein to control ratio.
Prohibitin and CRIF1 contribute to mitochondrial protein
synthesis
In addition to being identified in multiple TAPs of mtDNA
binding proteins (Table 1), prohibitin co-fractionated with
mtDNA and mitochondrial ribosomes (Figure 1e). These
results support the earlier assignment of prohibitin as a
mitochondrial nucleoid interacting factor (7,8,34), and
suggest that prohibitin is associated with ribonucleoprotein
complexes, as well as mtDNA. Given these similarities,
prohibitinmight, like ATAD3, contribute tomitochondrial
translation. Prohibitin forms oligomeric rings composed of
two proteins, prohibitin 1 and 2 in equimolar amounts;
neither protein can form a complex alone, and each is
rapidly turned over in the absence of the other (35).
Therefore, targeting either gene should be equally effective.
Figure 3. Elevated expression of ATAD3B.HA perturbs mtDNA topology, protein-dependent mtDNA multimers and mitochondrial replication
intermediates. (A) HEK293T cells expressing ATAD3B.HA for 5 days were DNA stained with picogreen and the mitochondrial network was labelled
with mitotracker orange (pseudo-coloured red for contrast). (B) Mitochondrial nucleoprotein was isolated from HEK293T cells expressing
ATAD3B.HA for 3 or 5 days (50 ng/ml doxycycline), and from (control) cells cultured without the drug. The DNA was digested with AccI,
separated by 2D-AGE and hybridized to a probe detecting the major non-coding region of human mtDNA [see Ref. (41) for a detailed exposition
of the protein-dependent multimers of mtDNA labelled x2, x3, d and w]. (C) Mitochondrial replication intermediates of cells induced to express
ATAD3B.HA and controls. Samples and processing were identical to panel B except that the DNA was treated additionally with proteinase K
during the isolation procedure. Note the enhanced standard replication fork (y) arc after 120 h expression of ATAD3B.HA in panels (B) and (C).
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Prohibitin 1 was targeted with dsRNA in human cultured
cells and found to severely impair mitochondrial protein
synthesis (Figure 4a), and excision of the PHB2 gene in
mouse embryonic fibroblasts (MEFS) also impaired mito-
chondrial protein synthesis (Figure 4b), albeit to a lesser
extent. The apparently milder impairment of protein syn-
thesis after (PHB2) gene excision, as compared to (PHB1)
siRNA, can be explained by the former treatment causing
more cell death (based on visual inspection) and the reten-
tion of the gene by some of the MEFs (Supplementary
Figure S10-A). Moreover, the loss of prohibitin is
accompanied by a marked inhibition of cell growth in
MEFs (35), which may attenuate the mitochondrial trans-
lation phenotype.
CRIF1 appeared to be an unlikely nucleoid interacting
protein (Table 1) or partner of ATAD3 (Table 4), because
it was reported to be a nuclear protein (36). However, the
recombinant CRIF1 studied previously carried a tag at its
amino terminus, and tags so positioned are well known to
mask mitochondrial targeting signals (MTS). In contrast,
CRIF1 tagged at the carboxy-terminus was targeted ex-
clusively to mitochondria (Figure 5a), suggesting that the
protein has an archetypal amino terminal MTS, as pre-
dicted by several algorithms (PSORTII, Target P,
Mitoprot and Predator), and a carboxy-terminal nuclear
localization signal. A CRIF1-GFP fusion protein was also
targeted to mitochondria (37). Mitochondrial targeting of
CRIF1 (Figure 5a) explains the identification of the
protein in two of five TAP experiments (Table 1).
Moreover, the protein co-fractionated with mtRNA on
iodixanol gradients (Figure 1e) and gene silencing of
CRIF1 with either of two siRNAs resulted in markedly
decreased mitochondrial protein synthesis (Figure 5b and
Supplementary Figure S10-B). Therefore, we conclude
that CRIF1 is a mitochondrial protein with a role in
protein synthesis in the organelle, which furthermore
might act as the link between ATAD3 and the mitochon-
drial ribosome (Figure 1f).
ATAD3 and prohibitin are linked to nucleoids and the
mitochondrial translation machinery
Based on this report, ATAD3 has roles in DNA metabol-
ism and protein synthesis in mitochondria, and it appears
to be physically and functionally allied to prohibitin.
ATAD3 and prohibitin co-purify with TFAM or SSBP1
affinity-captured nucleoids (Table 1); they co-fractionate
with mitochondrial nucleic acids on iodixanol gradients
(Figure 1e) and gene silencing of PHB or ATAD3 has
the same effect on mtDNA (2,38). Both ATAD3 and the
putative scaffold rings of prohibitin are required for
normal mitochondrial morphology (4,35) and mitochon-
drial translation (Figures 1g and 4). Collectively, these
results suggest that the two proteins have multiple,
overlapping roles in mitochondrial biogenesis and mito-
chondrial nucleic acid metabolism.
GTPases are used extensively to drive ribosome biogen-
esis in bacteria (39), and the ATPase of ATAD3 might be
employed to similar effect, although this would imply the
protein has fundamentally different roles in translation
and mtDNA organization. Alternatively, the protein
might have a structural role. The first report of ATAD3
found that only a fraction of the protein co-localizes with
mtDNA. It also forms ‘threads’ throughout much of the
mitochondrial network and both ATAD3 and mtDNA
are tightly associated with mitochondrial membranes (2).
Therefore, ATAD3 might form a filament to which mito-
chondrial nucleoids and mitochondrial ribosomes attach,
Figure 4. Decreased expression of prohibitin impairs mitochondrial protein synthesis. (A) Mitochondrial translation was assayed in mock transfected
143B cells (C) or cells transfected with a scrambled dsRNA (Sc), or with dsRNA targeting PHB1 (Ri) and separated by SDS–PAGE (4–12%
Nu-PAG, Invitrogen). Decreased expression of the target protein was confirmed by immunoblotting of PHB1 with GAPDH as the reference protein.
(B) The PHB2 gene was ablated in 90% of cells by incubating MEFs, whose sole copy of PHB2 is flanked by flox sites, with cre-recombinase
[Supplementary Figure S10-A and Ref. (42)]. C, control MEFs, PHBflx/flx MEFs with flox sites flanking the prohibitin 2 (PHB2) gene. Cre,
cre-recombinase that excises the PHB2 gene; , no cre added; +, one dose of cre; ++, two doses of cre (see Supplementary Figure S10-A).
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perhaps aided by prohibitin. This hypothesis ‘while tenta-
tive’ is compatible with the distribution of ATAD3 in cells
and its tight association with mitochondrial membranes
and mtDNA (2,7); the co-purification of ATAD3,
prohibitin and components of the 55S ribosomes with
mtDNA binding proteins (Table 1), and the mtDNA
related phenotypes associated with ATAD3 gene-silencing
and over-expression (Figures 2 and 3) (2); while also
accommodating the findings that a majority of endogen-
ous ATAD3 co-fractionates with mtRNA (Figure 1e), the
major binding partner of recombinant ATAD3 is the
mitochondrial ribosome (Table 4), and RNA interference
of ATAD3 markedly impairs mitochondrial translation
(Figure 1g). The more marked effect of ATAD3 siRNA
on mitochondrial translation (Figure 1g) compared to
mtDNA copy number (2) implies that when ATAD3 is
scarce, nucleoids take precedence; and because mitochon-
drial translation is particularly important during periods
of maximal growth (40), ATAD3 (or prohibitin) deficiency
is expected to be felt most keenly in proliferating cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–4, Supplementary Figures 1–10
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